Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jacob Elkon"'
Publikováno v:
International Journal of Cancer Care and Delivery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::090932c139972576f79db400cf1a1de7
https://doi.org/10.53876/001c.73647
https://doi.org/10.53876/001c.73647
Autor:
Brittany Ricart, Alejandro Villagra, Yan Ma, Jacob Elkon, Satish Noonepalle, Brooke Burgess, Robert S. Siegel, Christian Zevallos-Delgado, Erica Palmer, Jianqing Lin
Publikováno v:
Oncologist
Lessons Learned Entinostat at the selected dose levels in combination with a standard dose of enzalutamide showed a promising safety profile in this small phase I study Background Entinostat inhibits prostate cancer (PCa) growth and suppresses Treg c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b400a1699fa9868a970f1bbebeb2b68
https://pubmed.ncbi.nlm.nih.gov/34427023
https://pubmed.ncbi.nlm.nih.gov/34427023
Autor:
Brooke Burgess, Alejandro Villagra, Yan Ma, Brittany Ricart, Jacob Elkon, Erica Palmer, Robert S. Siegel, Jianqing Lin
Publikováno v:
Journal of Clinical Oncology. 39:96-96
96 Background: Entinostat (SNDX-275, MS-275) is an oral histone deacetylase (HDAC) inhibitor with selectivity towards class I and IV HDACs. Entinostat inhibits prostate cancer (PCa) growth and suppresses Treg cell function in vitro and in vivo. The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e794dcf65d674c65abc5cfc0aad1a5d6
https://doi.org/10.1200/jco.2021.39.6_suppl.96
https://doi.org/10.1200/jco.2021.39.6_suppl.96
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 16:1166-1171
Prostate cancer is the most common cancer among American men and the second most common cause of cancer deaths among men. Treatment of prostate cancer remains a challenge. Despite decades of research, few cytotoxic chemotherapy agents have shown prom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477152e123d6fba1a25ece26a1241733
https://doi.org/10.2174/1871520616666160121113558
https://doi.org/10.2174/1871520616666160121113558
Publikováno v:
BMJ Case Rep
A 53-year-old man with a 1-year history of chronic lymphocytic leukaemia (CLL) presented with a left bicep mass. Biopsy and staging workup revealed Richter’s transformation (RT) Ann Arbor stage 1E diffuse large B-cell lymphoma in the bicep. The pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b2bda161c1e5caec8621235fda82cb
https://doi.org/10.1136/bcr-2018-225893
https://doi.org/10.1136/bcr-2018-225893
Publikováno v:
BMJ Case Reports. :bcr2016217055
We present a case of a 73-year-old woman with transfusion-dependent anaemia thought to be secondary to an unidentifiable inflammatory condition. Anaemia evaluation including multiple bone marrow biopsies was unrevealing, with the exception of a non-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366d68a3bfbb7a62a2bf0e33de017859
https://doi.org/10.1136/bcr-2016-217055
https://doi.org/10.1136/bcr-2016-217055